As of 2026-01-05, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 53.81 USD. This relative valuation is based on P/E multiples. With the latest stock price at 59.45 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -9.5%.
The range of the Relative Valuation is 46.38 - 66.09 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 19.4x | 17.5x |
| Forward P/E multiples | 19.2x - 22.3x | 20.3x |
| Fair Price | 46.38 - 66.09 | 53.81 |
| Upside | -22.0% - 11.2% | -9.5% |
| Date | P/E |
| 2026-01-02 | 21.95 |
| 2025-12-31 | 21.94 |
| 2025-12-30 | 21.78 |
| 2025-12-29 | 22.16 |
| 2025-12-26 | 22.13 |
| 2025-12-24 | 22.21 |
| 2025-12-23 | 22.57 |
| 2025-12-22 | 21.88 |
| 2025-12-19 | 22.57 |
| 2025-12-18 | 19.18 |
| 2025-12-17 | 19.12 |
| 2025-12-16 | 19.11 |
| 2025-12-15 | 19.24 |
| 2025-12-12 | 19.68 |
| 2025-12-11 | 19.56 |
| 2025-12-10 | 19.82 |
| 2025-12-09 | 19.84 |
| 2025-12-08 | 19.68 |
| 2025-12-05 | 19.71 |
| 2025-12-04 | 19.87 |
| 2025-12-03 | 20.05 |
| 2025-12-02 | 19.89 |
| 2025-12-01 | 20.31 |
| 2025-11-28 | 20.65 |
| 2025-11-26 | 20.50 |
| 2025-11-25 | 20.78 |
| 2025-11-24 | 20.49 |
| 2025-11-21 | 20.19 |
| 2025-11-20 | 19.37 |
| 2025-11-19 | 19.40 |
| 2025-11-18 | 19.99 |
| 2025-11-17 | 20.10 |
| 2025-11-14 | 20.20 |
| 2025-11-13 | 20.02 |
| 2025-11-12 | 20.42 |
| 2025-11-11 | 20.28 |
| 2025-11-10 | 19.44 |
| 2025-11-07 | 19.00 |
| 2025-11-06 | 19.14 |
| 2025-11-05 | 19.49 |
| 2025-11-04 | 19.39 |
| 2025-11-03 | 19.51 |
| 2025-10-31 | 19.78 |
| 2025-10-30 | 19.16 |
| 2025-10-29 | 19.14 |
| 2025-10-28 | 19.75 |
| 2025-10-27 | 19.44 |
| 2025-10-24 | 20.11 |
| 2025-10-23 | 20.14 |
| 2025-10-22 | 19.70 |